Sussex Research Laboratories Inc.
Global leader in carbohydrate synthesis and glycan-based drug delivery solutions for discovery through manufacturing.
Global leader in custom glycan, glycopeptide, and glycoconjugate synthesis for drug discovery and development. Offers CRO and CDMO services spanning preclinical R&D, custom carbohydrate synthesis, antibody development, and targeting ligand design with over 25 years of expertise. Headquartered in Canada.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Services
Indications
About this organization
Overview
Sussex Research Laboratories Inc. is a specialized contract research and manufacturing organization focused on glycoscience—the study of carbohydrates (glycans) and their roles in biological processes. The company serves as a global leader in carbohydrate synthesis, offering both custom synthesis services and an extensive portfolio of pre-made glycan-based products.
Core Services
Glycan Synthesis & Development
- Scalable, cost-effective synthesis of simple modified monosaccharides (e.g., GalNAc targeting ligands) to complex oligosaccharides (e.g., Sialyl Lewis X)
- Expertise in hepatic (GalNAc) and extra-hepatic drug delivery strategies
- Support for oligonucleotide, protein, lipid, and small-molecule-based applications
Glycopeptides & Peptides
- Over 20 years of leadership in glycopeptide synthesis
- Synthetic tumor-associated carbohydrate antigens (TACA) based on mucins, PSGL-1 mimetics, and glycopolypeptides
- World's largest inventory of well-defined glycoamino acid building blocks
- Expertise in glycated (fructosylated), glycolipid, lipid, and macrocyclic peptides
Antibody Development
- Carbohydrate-based antigen production for antibody screening and generation
- Glycan, glycopeptide, and glycolipid antigens with BSA, OVA, CRM, or KLH carrier protein conjugates
Targeting Ligands
- Cell-specific carbohydrate ligands (GalNAc, sialic acid-containing glycans) targeting lectin/carbohydrate-mediated drug delivery
- Receptor targeting: ASGPR, Galectins, Siglecs, Mannose-6-phosphate Receptor, Influenza HAs, Mannose Receptor (CD206)
- Applications in RNA and difficult therapeutic molecule delivery to specific tissues
Preclinical & GMP Manufacturing Support
- Connection to trusted network for pre-clinical and GMP manufacturing scale-up
- Transition support from development to large-scale production
Quality & Compliance
- ISO 9001:2015 certified
- Rigorous quality control protocols throughout synthesis
- Certificate of Analysis and analytical data documentation provided
Market Position
- Over 1,000 clients worldwide
- Over 25 years of industry experience
- Made in Canada with international recognition
- Expertise honed over decades in glycoscience research
Certifications
| Authority | Identifier | Source |
|---|---|---|
| ISO | ISO 9001:2015 | View |
Locations
Headquarters
Canada
Related companies
Similar profiles by shared services, modalities, and capabilities.
Hikal- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
Winkem Labs Pvt. Ltd.- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
Clearsynth- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
PHT International, Inc.- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
Lacamas Laboratories Inc.- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Laurus Labs
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
SEQENS- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
ARSI Canada Inc- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
Submit a verified review for this organization.
Markdown mirror: /companies/sussex-research.md